120 related articles for article (PubMed ID: 19363672)
1. Total dietary antioxidant index and survival in patients with glioblastoma multiforme.
Il'yasova D; Marcello JE; McCoy L; Rice T; Wrensch M
Cancer Causes Control; 2009 Oct; 20(8):1255-60. PubMed ID: 19363672
[TBL] [Abstract][Full Text] [Related]
2. Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study.
Tedeschi-Blok N; Lee M; Sison JD; Miike R; Wrensch M
BMC Cancer; 2006 Jun; 6():148. PubMed ID: 16749939
[TBL] [Abstract][Full Text] [Related]
3. Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma.
DeLorenze GN; McCoy L; Tsai AL; Quesenberry CP; Rice T; Il'yasova D; Wrensch M
BMC Cancer; 2010 May; 10():215. PubMed ID: 20482871
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.
Wrensch M; Rice T; Miike R; McMillan A; Lamborn KR; Aldape K; Prados MD
Neuro Oncol; 2006 Jan; 8(1):12-26. PubMed ID: 16443944
[TBL] [Abstract][Full Text] [Related]
5. Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study.
Russnes KM; Möller E; Wilson KM; Carlsen M; Blomhoff R; Smeland S; Adami HO; Grönberg H; Mucci LA; Bälter K
BMC Cancer; 2016 Jul; 16():438. PubMed ID: 27400803
[TBL] [Abstract][Full Text] [Related]
6. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
7. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA).
Lee M; Wrensch M; Miike R
Cancer Causes Control; 1997 Jan; 8(1):13-24. PubMed ID: 9051318
[TBL] [Abstract][Full Text] [Related]
8. Dietary total antioxidant capacity in relation to endometrial cancer risk: a case-control study in Italy.
Rossi M; Tavani A; Ciociola V; Ferraroni M; Parpinel M; Serafini M; Bellocco R; Zucchetto A; Montella M; Serraino D; Lagiou P; La Vecchia C
Cancer Causes Control; 2016 Mar; 27(3):425-31. PubMed ID: 26830899
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant intake from diet and supplements and risk of digestive cancers in middle-aged adults: results from the prospective NutriNet-Santé cohort.
Egnell M; Fassier P; Lécuyer L; Gonzalez R; Zelek L; Vasson MP; Hercberg S; Latino-Martel P; Galan P; Druesne-Pecollo N; Deschasaux M; Touvier M
Br J Nutr; 2017 Oct; 118(7):541-549. PubMed ID: 28927476
[TBL] [Abstract][Full Text] [Related]
10. The use of antioxidant vitamin supplements among oncological patients.
Mandecka A; Czekajło A; Goździk M; Różańska D; Kłaniewski T; Szuba A; Regulska-Ilow B
Adv Clin Exp Med; 2018 Oct; 27(10):1365-1369. PubMed ID: 30085420
[TBL] [Abstract][Full Text] [Related]
11. Dietary antioxidants, supplements, and risk of epithelial ovarian cancer.
Fleischauer AT; Olson SH; Mignone L; Simonsen N; Caputo TA; Harlap S
Nutr Cancer; 2001; 40(2):92-8. PubMed ID: 11962261
[TBL] [Abstract][Full Text] [Related]
12. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
13. Total dietary antioxidant capacity, individual antioxidant intake and breast cancer risk: the Rotterdam Study.
Pantavos A; Ruiter R; Feskens EF; de Keyser CE; Hofman A; Stricker BH; Franco OH; Kiefte-de Jong JC
Int J Cancer; 2015 May; 136(9):2178-86. PubMed ID: 25284450
[TBL] [Abstract][Full Text] [Related]
14. Dietary Antioxidant Intake and Human Papillomavirus Infection: Evidence from a Cross-Sectional Study in Italy.
Barchitta M; Maugeri A; La Mastra C; Rosa MC; Favara G; Lio RMS; Agodi A
Nutrients; 2020 May; 12(5):. PubMed ID: 32408636
[TBL] [Abstract][Full Text] [Related]
15. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus.
Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP; Buffler P; Corley DA
Am J Gastroenterol; 2008 Jul; 103(7):1614-23; quiz 1624. PubMed ID: 18494834
[TBL] [Abstract][Full Text] [Related]
16. Dietary antioxidant capacity is inversely associated with diabetes biomarkers: the ATTICA study.
Psaltopoulou T; Panagiotakos DB; Pitsavos C; Chrysochoou C; Detopoulou P; Skoumas J; Stefanadis C
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):561-7. PubMed ID: 20171855
[TBL] [Abstract][Full Text] [Related]
17. Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?
Yesil Cinkir H; Colakoglu Er H
Asia Pac J Clin Oncol; 2020 Oct; 16(5):e223-e227. PubMed ID: 32762134
[TBL] [Abstract][Full Text] [Related]
18. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M; Butowski N; Tran DD; Recht LD; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust SA; Iwamoto F; Drappatz J; O'Rourke DM; Wong M; Hamilton MG; Finocchiaro G; Perry J; Wick W; Green J; He Y; Turner CD; Yellin MJ; Keler T; Davis TA; Stupp R; Sampson JH;
Lancet Oncol; 2017 Oct; 18(10):1373-1385. PubMed ID: 28844499
[TBL] [Abstract][Full Text] [Related]
19. Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide.
Polley MY; Lamborn KR; Chang SM; Butowski N; Clarke JL; Prados M
Neuro Oncol; 2010 Mar; 12(3):274-82. PubMed ID: 20167815
[TBL] [Abstract][Full Text] [Related]
20. The survival impact of postoperative infection in patients with glioblastoma multiforme.
Bohman LE; Gallardo J; Hankinson TC; Waziri AE; Mandigo CE; McKhann GM; Sisti MB; Canoll P; Bruce JN
Neurosurgery; 2009 May; 64(5):828-34; discussion 834-5. PubMed ID: 19404146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
